3M Co. said Friday that it has bought diagnostic heart murmur software business owned by medical device company Zargis Medical Corp.
Maplewood-based 3M (NYSE: MMM) said in a news release that it purchased the Telesteth online auscultation software, Stethassist software, and Zargis Cardioscan heart sound analysis software products developed by Stamford, Conn.-based Zargis Medical.
“Together, Zargis Medical’s diagnostic software used in combination with the 3M Littmann Stethoscope Model 3200 helps improve patient outcomes and reduce overall health care costs,” Ingrid Blair, vice president of patient assessment in 3M’s Infection Prevention Division, said in the release.
3M said the products are the only FDA-approved diagnostic software to classify suspected systolic and diastolic heart murmurs.
Terms of the transaction were not disclosed.
Zargis is majority-owned by Freehold, N.J.-based Speedus Corp., but 3M holds a minority stake in Zargis and has had a marketing and distribution agreement with the company, the statement said.
Click here to read the news release.
estych@bizjournals.com
See all your followed company news on your personalized dashboard.
To access the full benefits of bizWatch and receive a weekly email with aggregated news on all the companies you are following, please provide your email address below.
You must have a bizjournals account to follow a company.
Please Log In or Register.
